CymaBay Therapeutics, Inc.·4

Jan 26, 6:33 PM ET

Shantharam Harish 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 26, 2024

Insider Transaction Report

Form 4
Period: 2024-01-24
Shantharam Harish
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-01-24+74,75074,750 total
    Exercise: $22.85Exp: 2034-01-23Common Stock (74,750 underlying)
  • Award

    Common Stock

    2024-01-24+20,12520,125 total
Footnotes (2)
  • [F1]The grant shall vest as to 1/4 of the shares on each of January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
  • [F2]The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES